Stephen Taub RA Capital’s Big Covid Bet The biopharma specialist recently invested $200 million in a company developing a vaccine and is raising money for a new blank-check company. Stephen Taub June 17, 2020 Stanley Erck, CEO of Novavax Inc. (Kevin Dietsch/UPI/Bloomberg)